Every absorption study leans on a handful of terms — bioavailability, AUC, Cmax, Tmax. Learn to read them and you can judge a supplement claim for yourself instead of taking anyone's word for it.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This page is educational, not medical advice — talk to a licensed clinician about your own situation.
When a bottle says 500 mg, that's the dose — how much you swallow. It says nothing about how much actually makes it into your bloodstream in a form your body can use. That second number is bioavailability, and it's almost always smaller. Sometimes dramatically so.
Bioavailability is the fraction of a dose that reaches systemic circulation intact. A nutrient has to dissolve, survive stomach acid and digestive enzymes, cross the intestinal wall, and get past the liver — which filters everything absorbed from the gut before it reaches the rest of you. Each step takes a cut.
This is why two products with the identical dose on the label can deliver wildly different amounts to your cells, and why 'more milligrams' isn't the same as 'more nutrient.' Once you understand the vocabulary of absorption, supplement marketing gets a lot easier to see through.
“Dose is what you swallow. Bioavailability is what you actually get. They're rarely the same number.”
Follow a single dose from the moment you swallow it. At each checkpoint, some is lost — and only what survives the whole gauntlet counts as bioavailable.
of the original dose still present
Checkpoint 01 / 05
Dose swallowed
The full amount printed on the label. This is the starting line, not the finish.
Illustrative percentages to show the shape of the problem; real losses vary enormously by nutrient and formulation. Some compounds clear these hurdles easily; fragile or fat-soluble ones often don't.
Here's the step most people never hear about. Everything absorbed from your gut doesn't go straight into general circulation — it's routed first, through the portal vein, directly to the liver. The liver's job is to screen what comes in, and it chemically alters or removes a big share before the rest is allowed through. That detour is called first-pass metabolism, and for many nutrients it's where most of the dose disappears.
Absorbed dose flows gut → portal vein → liver, where a large fraction is metabolized before the remainder reaches the bloodstream.
A nutrient carried in a phospholipid shell merges with the membrane and passes into the bloodstream, instead of being blocked or broken down.
To be absorbed at all, a nutrient has to cross the intestinal lining — a wall built from phospholipid membranes. Water-soluble compounds struggle to pass through a fatty barrier; fragile ones get degraded before they can. This is exactly the bottleneck a lipid carrier is built to solve: wrap the nutrient in the same phospholipids the membrane is made of, and it can merge straight through.
Absorption studies plot the concentration of a nutrient in the blood over time after a dose. Three numbers describe that curve — once you know them, you can read almost any bioavailability study.
Illustrative curve · hover to read it
The words that show up again and again in delivery research — defined without the jargon. Tap any card for a concrete example.
Here's the whole lesson in one chart: an identical dose delivered two ways. The formulation with the larger area under the curve — higher and more sustained — delivered more total nutrient, even though the milligrams on the label were the same.
Liposomal · AUC
519
Standard · AUC
55
Difference
≈10×
Illustrative curves to show how AUC, Cmax and Tmax read on a chart — not data from a specific product. Readouts are calculated from the illustrative curves above.
The methods of measuring absorption are mature and standardized. How much any given nutrient benefits from better delivery is where the variation lives.
This is foundational pharmacology, not a marketing angle: the amount you take and the amount that reaches circulation are distinct, and the gap can be large. AUC and Cmax are the standardized ways to measure it.
The liver's first-pass filtering is a well-characterized reason many oral compounds have low bioavailability — and a big part of why delivery strategy matters as much as dose.
Human pharmacokinetic studies have shown that lipid-based and liposomal delivery can increase the area under the curve for poorly absorbed nutrients like vitamin C versus a standard dose. The effect is real and measurable — and formulation-specific.
How much a nutrient benefits from improved delivery depends on why it was poorly absorbed in the first place. The framework is consistent; the magnitude has to be measured nutrient by nutrient, which is exactly what good studies do.
This is the lens behind everything Manna builds. We don't compete on how many milligrams we can cram onto a label — that's the easy number to inflate and the least meaningful. We care about AUC: how much nutrient actually reaches your bloodstream, and how long it stays there.
That's why we lead with liposomal and lipid-based delivery. We're not here to promise an outcome or a dose — that's between you and your clinician. We're here to make sure delivery isn't the reason a good ingredient quietly underperforms.
Now that you can read an absorption curve, see the delivery system designed to bend it — how a phospholipid shell helps more of a dose survive digestion.
Read the liposomal explainerReferences
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This page is educational, not medical advice — talk to a licensed clinician about your own situation.
